These findings demonstrate that fenofibrate inhibits cardiac hypertrophy and regulates HMGB1 translocation; therefore, we hypothesized that fenofibrate-mediated regulation of HMGB1 localization may also play a role in inhibiting the development of cardiac hypertrophy. This evidence concerns the gene HMGB1 and cardiac hypertrophy.